Skip to main content
. 2011 Dec 3;42(1):117. doi: 10.1186/1297-9716-42-117

Table 1.

Overview of samples collected during the trial.

Type of sample Total Frequency Pool Analysis Reason
F0;
before inoculation
3 calves per pool:
1: oral
2: no challenge
3a&b: T-tracheal
4a&b: Nasal
Faecal MAP shedding before infection
Faeces 13 per calf Week 1 F1-3 pi
Week 2 F4-6 pi
Week 3 F7-9 pi;
Each of 3 days following weekly inoculation.
3 samples of 2 calves per pool:
1a&b: oral
2a&b: no challenge
3a, b&c: T-tracheal
4a, b&c: Nasal
Liquid MAP culture with confirmation IS900 PCR Passive faecal MAP shedding after inoculation
Week 6 F10 pi 3 calves per pool:
1: oral
2: no challenge
3a&b: T-tracheal
4a&b: Nasal
Faecal MAP Shedding
Week 9 F11 pi Individually
Week 12 F12 pi Individually Faecal MAP Shedding
Dust 18; at each stall Week 11 pi Individually Liquid MAP culture with confirmation IS900 PCR Environmental contamination with MAP
Serum 2 per calf Week 0 pi
Week 12 pi
Individually Commercial JD-ELISA B-cell activation& seroconversion
Whole blood 1 per calf Week 12 pi Individually Bovigam® interferon gamma essay T-cell sensitisation
Tissue 18 (19*) per calf W 12 pi Individually Liquid MAP culture with confirmation IS900 PCR Tissue colonisation with MAP

Overview of the samples collected. Frequencies and time points of collection and tests used for analysis during the 12 week trial are described. Additionally, the reason for sampling is indicated. F = faecal sample, pi = post inoculation, T-tracheal = transtracheal. *an additional piece of lung was sampled from one calf.